MRCP Part 1 → Palliative medicine and end of life care
Palliative medicine and end of life care accounts for roughly 2% of the MRCP Part 1 blueprint. This bank has 89 items tagged to it.
Around 2% of the paper, per MRCP(UK) examination blueprints and regulations. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
A 68-year-old man with metastatic cancer is started on morphine for pain. A week later he has hard, infrequent stools and abdominal discomfort. He has no bleeding or weight change beyond his illness. What is the most likely diagnosis?
The point: Constipation means passing stools less often than normal, or with difficulty, and it is a common and often distressing problem in palliative and geriatric care. It helps to split it into primary (functional) constipation, where no clear cause is found, and secondary constipation, where something specific is driving it. The causes worth remembering are drugs (opioids most of all, but also anticholinergic drugs, iron tablets, calcium-channel blockers and antacids), metabolic problems (hypothyroidism, an underactive thyroid; hypercalcaemia, a raised blood calcium; hypokalaemia, a low blood potassium), a mechanical blockage in the bowel, and nerve disease. In palliative care, almost every patient on a strong opioid becomes constipated, because opioids slow the gut down. Unlike most other opioid side effects, the body never builds up tolerance to this one, so a stimulant laxative (usually together with an osmotic laxative, which pulls water into the bowel) is started at the same time as any strong opioid, rather than waiting for constipation to appear. The key safety step with a new case, especially in an older patient, is to check for the red flags of colorectal cancer: a lasting change in bowel habit, rectal bleeding, weight loss and iron-deficiency anaemia (anaemia from low iron stores). Any of these need proper investigation. Faecal impaction (a hard mass of stool stuck in the rectum) can cause overflow diarrhoea, liquid stool leaking past the blockage, which is easily mistaken for ordinary diarrhoea. Treatment combines basic steps, fluids, fibre and staying mobile, with laxatives matched to how they work: bulk-forming (ispaghula, which adds bulk to the stool), osmotic (macrogol or lactulose, which pull water into the bowel) and stimulant (senna or bisacodyl, which make the bowel contract), plus suppositories or enemas for impaction. The exam themes are opioid-induced constipation and its preventive laxative, the red flags that lead to cancer investigation, and matching the laxative type to the problem.
Source: BNF — constipation treatment summary British National Formulary · tier 3, national formulary
A 68-year-old man with metastatic cancer is started on morphine for pain. A week later he has hard, infrequent stools and abdominal discomfort. He has no bleeding or weight change beyond his illness. What is the most appropriate investigation?
The point: Constipation means passing stools less often than normal, or with difficulty, and it is a common and often distressing problem in palliative and geriatric care. It helps to split it into primary (functional) constipation, where no clear cause is found, and secondary constipation, where something specific is driving it. The causes worth remembering are drugs (opioids most of all, but also anticholinergic drugs, iron tablets, calcium-channel blockers and antacids), metabolic problems (hypothyroidism, an underactive thyroid; hypercalcaemia, a raised blood calcium; hypokalaemia, a low blood potassium), a mechanical blockage in the bowel, and nerve disease. In palliative care, almost every patient on a strong opioid becomes constipated, because opioids slow the gut down. Unlike most other opioid side effects, the body never builds up tolerance to this one, so a stimulant laxative (usually together with an osmotic laxative, which pulls water into the bowel) is started at the same time as any strong opioid, rather than waiting for constipation to appear. The key safety step with a new case, especially in an older patient, is to check for the red flags of colorectal cancer: a lasting change in bowel habit, rectal bleeding, weight loss and iron-deficiency anaemia (anaemia from low iron stores). Any of these need proper investigation. Faecal impaction (a hard mass of stool stuck in the rectum) can cause overflow diarrhoea, liquid stool leaking past the blockage, which is easily mistaken for ordinary diarrhoea. Treatment combines basic steps, fluids, fibre and staying mobile, with laxatives matched to how they work: bulk-forming (ispaghula, which adds bulk to the stool), osmotic (macrogol or lactulose, which pull water into the bowel) and stimulant (senna or bisacodyl, which make the bowel contract), plus suppositories or enemas for impaction. The exam themes are opioid-induced constipation and its preventive laxative, the red flags that lead to cancer investigation, and matching the laxative type to the problem.
Source: BNF — constipation treatment summary British National Formulary · tier 3, national formulary
A 68-year-old man with metastatic cancer is started on morphine for pain. A week later he has hard, infrequent stools and abdominal discomfort. He has no bleeding or weight change beyond his illness. What is the most appropriate management?
The point: Constipation means passing stools less often than normal, or with difficulty, and it is a common and often distressing problem in palliative and geriatric care. It helps to split it into primary (functional) constipation, where no clear cause is found, and secondary constipation, where something specific is driving it. The causes worth remembering are drugs (opioids most of all, but also anticholinergic drugs, iron tablets, calcium-channel blockers and antacids), metabolic problems (hypothyroidism, an underactive thyroid; hypercalcaemia, a raised blood calcium; hypokalaemia, a low blood potassium), a mechanical blockage in the bowel, and nerve disease. In palliative care, almost every patient on a strong opioid becomes constipated, because opioids slow the gut down. Unlike most other opioid side effects, the body never builds up tolerance to this one, so a stimulant laxative (usually together with an osmotic laxative, which pulls water into the bowel) is started at the same time as any strong opioid, rather than waiting for constipation to appear. The key safety step with a new case, especially in an older patient, is to check for the red flags of colorectal cancer: a lasting change in bowel habit, rectal bleeding, weight loss and iron-deficiency anaemia (anaemia from low iron stores). Any of these need proper investigation. Faecal impaction (a hard mass of stool stuck in the rectum) can cause overflow diarrhoea, liquid stool leaking past the blockage, which is easily mistaken for ordinary diarrhoea. Treatment combines basic steps, fluids, fibre and staying mobile, with laxatives matched to how they work: bulk-forming (ispaghula, which adds bulk to the stool), osmotic (macrogol or lactulose, which pull water into the bowel) and stimulant (senna or bisacodyl, which make the bowel contract), plus suppositories or enemas for impaction. The exam themes are opioid-induced constipation and its preventive laxative, the red flags that lead to cancer investigation, and matching the laxative type to the problem.
Source: BNF — constipation treatment summary British National Formulary · tier 3, national formulary
Clinical sciences · Clinical pharmacology and therapeutics · Cardiology · Respiratory medicine · Gastroenterology and hepatology · Neurology · Endocrinology, diabetes and metabolic medicine · Renal medicine · Infectious diseases · Rheumatology · Haematology · Psychiatry · Dermatology · Geriatric medicine · Oncology · Medical ophthalmology